Organ dysfunction as an outcome measure in clinical trials

European Journal of Surgery, Supplement

Volumn 164, Issue 584, 1999, Pages 62-67

  Marshall, John C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Clinical trials; Multiple organ dysfunction syndrome; Outcome measures

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CLINICAL TRIAL; COST; HUMAN; IMMUNOTHERAPY; INFECTION; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MODEL; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME; CLASSIFICATION; HEALTH CARE COST; HEALTH SURVEY; HEART SURGERY; HOSPITALIZATION; LENGTH OF STAY; MEDIASTINITIS; OUTCOME ASSESSMENT; REPRODUCIBILITY; SURGICAL INFECTION; SURVIVAL RATE; SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME;

CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS; HEALTH CARE COSTS; HEALTH STATUS INDICATORS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTENSIVE CARE; LENGTH OF STAY; MEDIASTINITIS; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURGICAL WOUND INFECTION; SURVIVAL RATE; SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 0032586353     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 1. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994; 271: 226-233.
2. 2. Bernard GR, Doig G, Hudson G, et al. Quantification of organ dysfunction for clinical trials in sepsis (abstract). Am J Respir Crit Care Med 1995; 151: A323.
3. 3. Cook DJ, Hebert PC, Heyland DK, et al. How to use an article on treatment or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med 1997; 25: 1502-1513.
4. 4. Deitch EA. Multiple organ failure. Pathophysiology and potential future treatment. Ann Surg 1992; 216: 117-134.
5. 5. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781-788.
6. 6. Elebute EA, Stoner HB. The grading of sepsis. Br J Surg 1983; 70: 29-31.
7. 7. Fry DE, Pearlstein L, Fulton RL, Polk HC. Multiple system organ failure. The role of uncontrolled infection. Arch Surg 1980; 115: 136-140.
8. 8. Goris RJA, te Boekhorst TPA, Nuytinck JKS, Gimbrere JSF. Multiple organ failure. Generalised autodestructive inflammation? Arch Surg 1985; 120: 1109-1115.
9. 9. Guyatt GH, Meade MO. Outcome measures: methodologic principles. Sepsis 1997; 1: 21-25.
10. 10. Guyatt GH, Veldhuysen van Santen SJO, Feeney DH, Patrick DL. Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J 1989; 140: 1441-1448.
11. 11. Hebert PC. Mortality as an outcome in sepsis trials. Sepsis 1997; 1: 35-40.
12. 12. Keene AR, Cullen DJ. Therapeutic intervention scoring system: Update 1983. Crit Care Med 1983; 11: 1-3.
13. 13. Le Gall JR, Klar J, Lemeshow S, et al. The logistic organ dysfunction system - A new way to assess organ dysfunction in the intensive care unit. JAMA 1996; 276: 802-810.
14. 14. Marshall JC. Infection and the host septic response contribute independently to adverse outcome in critical illness: implications for clinical trials of mediator antagonism. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer Verlag, 1994: 1-13.
15. 15. Marshall JC. Multiple organ dysfunction syndrome (MODS). In: Sibbald WJ, Vincent J-L, eds. Clinical trials for the treatment of sepsis. Berlin: Springer-Verlag, 1995: 122-138.
16. 16. Marshall JC, Bernard G, Le Gall J, Vincent J-L. The measurement of organ dysfunction/failure as an ICU outcome. Sepsis 1997; 1: 41-57.
17. 17. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23: 1638-1652.
18. 18. Marshall JC, Sweeney D. Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome. Arch Surg 1990; 125: 17-23.
19. 19. Petros AJ, Marshall JC, van Saene HKF. Is mortality an appropriate endpoint for clinical trials in critical illness? Lancet 1995; 345: 369-371.
20. 20. Russell JA, Singer J, Bernard G. Multiple organ dysfunction evaluation system (MODES): validation in sepsis syndrome. Am Rev Respir Crit Care Med 1995: Abstract.
21. 21. Skillman JJ, Bushnell LS, Goldman H, Silen W. Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage and acute stress ulceration in the stomach. Am J Surg 1969; 117: 523-530.
22. 22. Vincent JL, Moreno R, Takala J, et al. The sepsis-related organ failure assessment (SOFA) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707-710.